metabolic works, page-12

you are very long this stock jevelent......certainly a credit to you, that never overly try to talk up the stock.

However can I point out, they have a pain drug that has no real competition in a $5 billion market place. Phase 2 trials are underway now.

IF and yes...I do mean IF, the drug got to market....MBP would derive at least 10% of revenues from all drug sales of ACV1. Lets say that only $1b of market share is achieved.

That is still $100 m gross revenues (and a shareprice of $3) for MBP.

Yes I know what you might say......even you jevalent (much less the other newbies)......that MBP has a long way to go before approvals and sales are generated.......but the whole point is the share price now is 16 cents.

Look I can tell you.....IF they get throught (phase 2-resuts soon) we have a $120m company here.....which means a shareprice of 40 cents.

Can I suggest .....you